Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jerzy Dropinski is active.

Publication


Featured researches published by Jerzy Dropinski.


Clinical Rheumatology | 2005

Eosinophilic fasciitis successfully treated with cyclosporine

Aleksandra Bukiej; Jerzy Dropinski; Grzegorz Dyduch; Andrzej Szczeklik

We report on a 45-year-old female who developed eosinophilic fasciitis, characterized by scleroderma-like skin indurations, predominantly on the extremities and chest, with joint contractures and intermittent blood eosinophilia. Histologic examination revealed fibrosis of muscle fascia and eosinophilic infiltration. High-dose systemic corticosteroid therapy was ineffective, but cyclosporine treatment led to remission.


Hypertension | 2012

Nitric Oxide Production and Endothelium-Dependent Vasorelaxation Ameliorated by N1-Methylnicotinamide in Human Blood Vessels

Teresa B. Domagala; Agata Szeffler; Lawrence W. Dobrucki; Jerzy Dropinski; Stanisław Polanski; Magdalena Leszczynska-Wiloch; Katarzyna Kotula-Horowitz; Jacek Wojciechowski; Leszek Wojnowski; Andrzej Szczeklik; Leszek Kalinowski

N 1-methylnicotinamide (MNA+) has until recently been thought to be a biologically inactive product of nicotinamide metabolism in the pyridine nucleotides pathway. However, the latest observations imply that MNA+ may exert antithrombotic and anti-inflammatory effects through direct action on the endothelium. We examined both in vivo and in vitro whether the compound might induce vasorelaxation in human blood vessels through the improvement of nitric oxide (NO) bioavailability and a reduction of oxidative stress mediated by endothelial NO synthase (eNOS) function. MNA+ treatment (100 mg/m2 orally) in healthy normocholesterolemic and hypercholesterolemic subjects increased the l-arginine (l-NMMA)-inhibitable flow-mediated dilation (FMD) of brachial artery responses that also positively correlated with MNA+ plasma concentrations (r=0.73 for normocholesterolemics and r=0.78 for hypercholesterolemics; P<0.0001). MNA+ increased FMD at the same concentration range at which it enhanced NO release from cultured human endothelial cells after stimulation with either the receptor-dependent (acetylcholine) or the receptor-independent endothelial NO synthase agonists (calcium ionophore A23187). MNA+ restored the endothelial NO synthase agonist-stimulated NO release after the exposure of the cells to oxidized low-density lipoprotein. This effect was also associated with the normalization of the [NO]/[superoxide] balance in the endothelial cells. Taken together, the increased NO bioavailability in the endothelium contributes to the vasorelaxating properties of MNA+. Targeting eNOS with MNA+ might be therapeutically relevant for functional disorders of the endothelium, such as hypercholesterolemia and atherosclerosis.


PLOS ONE | 2015

The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function - An Occupational Cohort-Based Study

M. Janczura; Grazyna Bochenek; Roman Nowobilski; Jerzy Dropinski; Katarzyna Kotula-Horowitz; Bartosz Laskowicz; A. Stanisz; Jacek Lelakowski; Teresa B. Domagala

Background and Aims Higher levels of stress impact the prevalence of metabolic syndrome (MetS) and coronary heart disease. The association between MetS, impaired pulmonary function and low level of physical activity is still pending assessment in the subjects exposed to stress. The study aimed to examine whether higher levels of stress might be related to MetS and the plaque presence, as well as whether MetS might affect pulmonary function. Design and Methods The study embraced 235 police officers (mean age 40.97 years) from the south of Poland. The anthropometrics and biochemical variables were measured; MetS was diagnosed using the International Diabetes Federation criteria. Computed tomography coronary angiography of coronary arteries, exercise ECG, measurements of brachial flow-mediated dilation, and carotid artery intima-media thickness were completed. In order to measure the self-perception of stress, 10-item Perceived Stress Scale (PSS-10) was applied. Pulmonary function and physical activity levels were also addressed. Multivariate logistic regression analyses were applied to determine the relationships between: 1/ incidence of coronary plaque and MetS per se, MetS components and the number of classical cardiovascular risk factors, 2/ perceived stress and MetS, 3/ MetS and pulmonary function parameters. Results Coronary artery atherosclerosis was less associated with MetS (OR = 2.62, 95%CI 1.24–5.52; p = 0.011) than with a co-existence of classical cardiovascular risk factors (OR = 5.67, 95% CI 1.07–29.85, p = 0.03; for 3 risk factors and OR = 9.05; 95% CI 1.24–66.23, p = 0.02; for 6 risk factors, respectively). Perceived stress increased MetS prevalence (OR = 1.07, 95% CI 1.03–1.13; p = 0.03), and impacted coronary plaque prevalence (OR = 1.05, 95% CI 1.001–1.10; p = 0.04). Leisure-time physical activity reduced the chances of developing MetS (OR = 0.98 95% CI 0.96–0.99; p = 0.02). MetS subjects had significantly lower values of certain pulmonary function parameters. Conclusions Exposure to job-specific stress among police officers increased the prevalence of MetS and impacted coronary plaque presence. MetS subjects had worse pulmonary function parameters. Early-stage, comprehensive therapeutic intervention may reduce overall risk of cardiovascular events and prevent pulmonary function impairment in this specific occupational population.


American Journal of Medical Genetics | 2001

Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia

Andrzej Szczeklik; Marek Sanak; Miłosz Jankowski; Jerzy Dropinski; Renata Czachór; Jacek Musial; Irena Axenti; Magdalena Twardowska; Tomasz Brzostek; Michał Tendera


Thrombosis Research | 2007

Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease

Jerzy Dropinski; Jacek Musial; Marek Sanak; Wojciech Węgrzyn; Rafał Niżankowski; Andrew Szczeklik


Thrombosis Research | 2003

Aspirin and thrombinogenesis

A. Szczeklik; Jacek Musial; Anetta Undas; Marek Sanak; Jerzy Dropinski; E Tuleja; Wojciech Węgrzyn


Atherosclerosis | 2018

Plasma but not urine 8-ISO-PGF2ALFA is a predictor of insulin resistance in the middle-aged subjects – An occupational, cohort-based study

M. Janczura; Anna Gielicz; Katarzyna Kotula-Horowitz; Teresa Iwaniec; A. Stanisz; R. Rosa; Jerzy Dropinski; Teresa B. Domagala


Atherosclerosis | 2016

Association of insulin resistance, as determined by homeostasis model assessment (HOMA), with metabolic syndrome among middle-aged subjects

M. Janczura; K. Kotula-Horowitz; T. Iwaniec; A. Stanisz; Jerzy Dropinski; Teresa B. Domagala


Atherosclerosis | 2016

Association of insulin resistance with carotid intima-media thickness and brachial flow-mediated dilation in the subjects with metabolic syndrome

Teresa B. Domagala; M. Janczura; K. Kotula-Horowitz; Jerzy Dropinski; T. Iwaniec; J. Zagajewski; A. Stanisz


Atherosclerosis | 2016

Relationship of stress with metabolic syndrome and coronary heart disease in middle-aged police officers

M. Janczura; Jerzy Dropinski; A. Stanisz; K. Kotula-Horowitz; R. Rosa; Teresa B. Domagala

Collaboration


Dive into the Jerzy Dropinski's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Stanisz

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Andrzej Szczeklik

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacek Musial

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Marek Sanak

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

T. Iwaniec

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge